<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A795188F-66D2-4CB7-BCCE-4E65A775618A"><gtr:id>A795188F-66D2-4CB7-BCCE-4E65A775618A</gtr:id><gtr:firstName>Tim</gtr:firstName><gtr:surname>Elliott</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400767"><gtr:id>736086A8-7FC0-482B-BD7E-85C0010E11A0</gtr:id><gtr:title>Glycosylation, oxidative folding and antigenicity: a case study using retroviral gp90</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400767</gtr:grantReference><gtr:abstractText>1. Cancer Sciences Division annual open day.
2. Science / Art collaboration with the Winchester School of Art.</gtr:abstractText><gtr:technicalSummary>The recognition by CD4+ T cells of antigens derived from glycoproteins is central to the development of protective immune responses to pathogens such as viruses and to tumours. Because T cells recognise small proteolytic fragments of these antigens, presented to their T cell receptors by molecules encoded by the class II major histocompatibility complex (MHC II), it has long been assumed that antigen conformation is not an important factor in determining their antigenicity. However, the processing of antigens for presentation by MHC class II molecules is controlled by factors in the intracellular antigen processing compartments such as pH, oxidoreductases and proteases. It is likely, therefore that the susceptibility of protein antigens to these factors will depend upon their structural characteristics such as stability at low pH and presence of stabilising intramolecular disulphide bonds. We have described a T lymphocyte response that is sensitive to antigen conformation - the recognition of a viral glycoprotein called gp90 - which serves as a tumour specific antigen in a murine model of colon cancer. Our initial observations indicate that the antigenic conformation of gp90, which is an immature precursor to the cell-surface expressed gp70, has non-native intramolecular disulphide bonds and is required to be glycosylated. This is an important observation because it shows for the first time that the generation of an immune response may in some instances be controlled by the intracellular ?folding? environment that is experienced by immunodominant antigens during their synthesis. Understanding the cellular biochemistry that underpins this phenomenon could help explain how, for example cryptic epitopes that in one context are thought to initiate some autoimmune diseases and in another are sought as potential targets for anti-tumour immunotherapy might be generated from the same polypeptide sequence expressed in different cellular contexts. This project proposes to investigate the way in which minor differences in the way proteins are folded might control the way in which they are recognised by T cells. In the first instance we will do this by establishing a link between two particular steps in the folding of the gp90 molecule: the formation of disulphide bridges and the acquisition of carbohydrate side-chains. We will also attempt to identify the differences between cells that can and those that cannot generate the antigenic conformation of gp90.</gtr:technicalSummary><gtr:fund><gtr:end>2009-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>241243</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CRUK Programme</gtr:description><gtr:id>85683810-225E-4769-BD83-7C1ACBFF370F</gtr:id><gtr:impact>PMID: 19196713 PMID: 17389359</gtr:impact><gtr:outcomeId>F60EDDEC0BD-1</gtr:outcomeId><gtr:partnerContribution>Infrastructure</gtr:partnerContribution><gtr:piContribution>Principal Investigator</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Role of redox enzyme ERp57 in the assembly of MHC class I molecules</gtr:description><gtr:id>4ED5276A-AB44-450F-A570-99B01F583765</gtr:id><gtr:impact>student presented his data at the 7th International Calreticulin Workshop in Niagara Falls in 2006. The joint publication appeared in 2009 (19196713).</gtr:impact><gtr:outcomeId>8FA7432C092-1</gtr:outcomeId><gtr:partnerContribution>Expertise and know-kow on the function of redox enzymes and carbohydrate-binding chaperones.</gtr:partnerContribution><gtr:piContribution>As a result of our investigations into the role of ERp57 in antigen folding: the subject of the MRC-funded grant, we generated calreticulin mutants that lacked the ability to bind to ERp57 and hence form a trimolecular complex with client proteins (in the published case this was MHC class I molecules - a subject of specialist interest of both my lab and the collaborator lab). During conversations with collaborator, I realised that we were pursuing complementary pathways to the same end: he was making ERp57 mutants that lacked the ability to bind to calreticulin. We agreed to pool our resources and the joint-authored paper is the result. In addition to contributing the complementary construct - we performed all the antigen presentation experiments using an assay that my PhD student had developed.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Artist in Residence</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>955B4724-18FF-4D17-9808-AC351A0F33F7</gtr:id><gtr:impact>Series of externally funded art collaborations with scientists in the School of Medicine, hosted by my lab. Often used as a focal point for engagement with the public about our research.

September 2009. Faith - touring solo show. Funded by the Arts Council (http://www.faithinteractive.co.uk). February 2008. A North + South Commission: The North + South Project was staged across six unique exhibitions, in galleries at the northern and southernmost ends of England, it features over thirty artists, including Pauline Pratt presenting a collaborative piece called Motley Assortment. April 2007. Various 3 mins films relating to collaborations within the Cancer Science Division. Site: Plasma Screen, Somers Building, Cancer Science Division, University of Southampton, Southampton General Hospital. July 2006 Prophecy - Group show. The Waiting Room Installation consisting of slide projections, film and collaborative work with researchers in the Cancer Science Division, University of Southampton Site: Arch 07, Southampton January 2006: Common Denominator - Solo Show Winchester School of Art Numerous Media articles, including BBC radio and TV, local and national press over this period.</gtr:impact><gtr:outcomeId>A751E9166D4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visits</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>E1D57C9D-4BB8-49E9-B8CD-378315066AFC</gtr:id><gtr:impact>Several locations in area: Years 6 - 11 students purify, stain and observe DNA under low magnification, initially in the context of a scientific investigation but with seamless shift of context into making art.

DVD's produced by host schools in collaboration with artist.</gtr:impact><gtr:outcomeId>A521AB8E51E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cancer Sciences Open Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>92E6A27A-2A12-4B31-9DBD-BAFB0B0D5D6A</gtr:id><gtr:impact>Welcome address, interactive talk on the power of the immune system and principles of vaccination, Lab Tours with practical demonstrations, informal mixing over drinks/tea.

Consistent positive feedback from both individuals and group organisers (for example local fundraisers). Visits have also strengthened our resolve to use collaborative art as a focal point for engaging with the public about biomedicine. See seperate entry.</gtr:impact><gtr:outcomeId>BB7CE0A402F</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edinburgh Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>DEBC5D3A-C934-448E-B4C6-7C4807CD0444</gtr:id><gtr:impact>Public Lecture on tumour immunology

various press releases</gtr:impact><gtr:outcomeId>455C2777DEE</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>220000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project Grant</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>900C7571-6DC2-4FF4-8DA9-6CE8380241E7</gtr:id><gtr:outcomeId>F0F2BF8DCC70</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Internal studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>University of Southampton</gtr:fundingOrg><gtr:id>EB384233-8519-404A-BC60-670FE962E4E0</gtr:id><gtr:outcomeId>jAiBo6MnBTB0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>ERp57 with partial loss-of-function mutations</gtr:description><gtr:id>E8F955A3-64F8-42F0-AAD9-285C64207E9C</gtr:id><gtr:impact>Publication</gtr:impact><gtr:outcomeId>7CD6EB8BB3F</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ERp57 mutants</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>77BB9899-D976-4922-AFFB-C818874EBE73</gtr:id><gtr:title>Differential suppression of tumor-specific CD8+ T cells by regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4079763d549021db8c9b92ebed6b1e2"><gtr:id>e4079763d549021db8c9b92ebed6b1e2</gtr:id><gtr:otherNames>James E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>JCC3E4R8YqG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1592CB2-A123-46A5-8F06-310FBF1324A3</gtr:id><gtr:title>Folding of an MHC class II-restricted tumor antigen controls its antigenicity via MHC-guided processing.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25eecc1d4b82a9fd8036a1da555a5b40"><gtr:id>25eecc1d4b82a9fd8036a1da555a5b40</gtr:id><gtr:otherNames>Mimura Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>4E99BCC2CE0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B858831-421B-4B3B-A2C6-E401DEC48FFD</gtr:id><gtr:title>ERp57 does not require interactions with calnexin and calreticulin to promote assembly of class I histocompatibility molecules, and it enhances peptide loading independently of its redox activity.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>DD1ECCBC7F8</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400767</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>